RK

Richard Kolesnick

MC Memorial Sloan Kettering Cancer Center: 12 patents #25 of 761Top 4%
SR Sloan Kettering Institute For Cancer Research: 8 patents #43 of 644Top 7%
University Of Texas System: 4 patents #745 of 6,559Top 15%
The General Hospital: 2 patents #806 of 3,021Top 30%
MU Michigan State University: 1 patents #495 of 1,164Top 45%
📍 New York, NY: #680 of 20,192 inventorsTop 4%
🗺 New York: #5,811 of 115,490 inventorsTop 6%
Overall (All Time): #176,976 of 4,157,543Top 5%
23
Patents All Time

Issued Patents All Time

Showing 1–23 of 23 patents

Patent #TitleCo-InventorsDate
12214218 Perfusion modulated tumor dose sculpting with single dose radiotherapy Zvi Fuks, Carlo Greco 2025-02-04
12121525 Methods for treating GI syndrome and graft versus host disease Jimmy Andrew Rotolo, Renata Pasqualini, Wadih Arap 2024-10-22
12036212 Enhancement of tumor response to chemotherapy by activation of the asmase/ceramide pathway through timed administration of a short-acting anti-angiogenic agent Adriana Haimovitz-Friedman, Evis Sala, Zvi Fuks 2024-07-16
11447572 Anti-ceramide antibodies Jimmy Andrew Rotolo 2022-09-20
11285137 Enhancement of tumor response to chemotherapy by activation of the asmase/ceramide pathway through timed administration of a short-acting anti-angiogenic agent Adriana Haimovitz-Friedman, Evis Sala, Zvi Fuks 2022-03-29
11207329 Methods for treating GI syndrome and graft versus host disease Jimmy Andrew Rotolo, Renata Pasqualini, Wadih Arap 2021-12-28
10975169 Methods for treating diabetic retinopathy using anti-ceramide monoclonal antibody 2A2 Julia Busik 2021-04-13
10722577 Methods for treating GI syndrome and graft versus host disease Jimmy Andrew Rotolo 2020-07-28
10450385 Anti-ceramide antibodies Jimmy Andrew Rotolo 2019-10-22
10413533 Enhancement of tumor response to chemotherapy by activation of the ASMase/ceramide pathway through timed administration of a short-acting anti-angiogenic agent Adriana Haimovitz-Friedman, Evis Sala, Zvi Fuks 2019-09-17
10052387 Ceramide reversal of multi-drug resistance Yechezkel Barenholz, Erez Koren 2018-08-21
9592238 Anti-ceramide monoclonal antibody 2A2 Jimmy Andrew Rotolo, Renata Pasqualini, Wadih Arap 2017-03-14
8562993 Methods for treating GI syndrome and graft versus host disease Jimmy Andrew Rotolo, Renata Pasqualini, Wadih Arap 2013-10-22
8283459 Kinase suppressor of Ras inactivation for therapy of Ras mediated tumorigenesis Hongmei R. Xing 2012-10-09
8258108 Kinase suppressor of Ras inactivation for therapy of Ras mediated tumorigenesis Hongmei R. Xing 2012-09-04
7850984 Protection of the female reproductive system from natural and artificial insults Jonathan L. Tilly 2010-12-14
7528116 Kinase suppressor of Ras inactivation for therapy of Ras mediated tumorigenesis Hongmei R. Xing 2009-05-05
7301017 Kinase suppressor of Ras inactivation for therapy of Ras mediated tumorigenesis Hongmei R. Xing 2007-11-27
7195775 Protection of the female reproductive system from natural and artificial insults Jonathan L. Tilly 2007-03-27
6790627 Methods and compositions for the modulation of acid-sphingomyelinase-related apoptosis Edward H. Schuchman 2004-09-14
6274309 Method for the modulation of acid-sphingomyelinase-related apoptosis Edward H. Schuchman 2001-08-14
6040149 Assay for identifying agents which act on the ceramide-activated protein kinase, kinase suppressor of ras, and methods of using said agents Jun O. Liu, Yuhua Zhang 2000-03-21
5451518 Purified human ceramide-activated protein kinase 1995-09-19